Work

Real-world Therapeutic Drug Monitoring of Dalbavancin Following a Dose Regimen of 1,500 Mg at Day 1, 15, and 43

Year: 2025

Type: article

Study design: Observational Study

Source: Orthopaedic Proceedings

DOI: 10.1302/1358-992x.2025.12.015

Authors: Thomas Lin, Eric Senneville, Benjamin Hennart, Benjamin Valentin, Barthelemy Lafon-Desmurs, Anne Boucher, Maxime Pradier, Pierre Patoz, Olivier Robineau, Benoît Gachet

Institutions: Centre Hospitalier de Tourcoing, Centre Hospitalier Universitaire de Lille

Language: English

Topic: Antibiotics Pharmacokinetics and Efficacy

Subfield: Pharmacology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4415871793

FWCI:

Cites:

Cited by:

Related to: